Assembly Biosciences
ASMB
24 hedge funds and large institutions have $8.61M invested in Assembly Biosciences in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 20 closing their positions.
1.33% less ownership
Funds ownership: 13.14% → 11.81% (-1.3%)
10% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 10
45% less funds holding
Funds holding: 44 → 24 (-20)
56% less capital inflows, than outflows
Capital inflows: $509K | Capital outflows: $1.16M
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 20
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Acuitas Investments
Seattle,
Washington
|
+$322K |
| 2 |
Marquette Asset Management
Minneapolis,
Minnesota
|
+$52.2K |
| 3 |
Millennium Management
New York
|
+$47.6K |
| 4 |
Renaissance Technologies
New York
|
+$41.8K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$16.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Anson Funds Management
Dallas,
Texas
|
-$590K |
| 2 |
Two Sigma Investments
New York
|
-$111K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$102K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$58.9K |
| 5 |
Franklin Resources
San Mateo,
California
|
-$53.6K |
ASMB Hedge Fund Activity: Q1 2024 in Review
24 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q1 2024, worth a combined $8.61M — up 21% from $7.09M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of ASMB and 0 opened new positions — a net loss of 20 holders — while 10 trimmed existing stakes and 9 added.
The largest buyer was Acuitas Investments, adding an estimated $322K. The largest seller was Anson Funds Management, exiting entirely with an estimated $590K sold.
- 24 institutional investors held Assembly Biosciences (ASMB) as of Q1 2024, down from 44 in Q4 2023.
- Funds reported $8.61M of Assembly Biosciences stock for Q1 2024, up 21% quarter-over-quarter.
- 0 funds opened new Assembly Biosciences positions in Q1 2024 and 20 closed out, a net change of -20 holders.
- The largest Assembly Biosciences buyer in Q1 2024 was Acuitas Investments, an estimated $322K added.
- The largest Assembly Biosciences seller in Q1 2024 was Anson Funds Management, an estimated $590K sold.
Based on aggregated 13F filings for Q1 2024.